MYND Life Sciences Inc.

MYND Life Sciences develops novel psychedelic pharmaceuticals aimed at treating mental health disorders such as depression and anxiety. By utilizing advanced drug formulation techniques, the company seeks to enhance therapeutic efficacy and improve patient outcomes in the life sciences sector.

Traction 4/10

Kelowna, Canada · HQ

Founded 20163300+ followers

Biotechnology

Updated 7 months ago

Funding

Raised to date

$1.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

MYND Life Sciences develops novel psychedelic pharmaceuticals aimed at treating mental health disorders such as depression and anxiety. By utilizing advanced drug formulation techniques, the company seeks to enhance therapeutic efficacy and improve patient outcomes in the life sciences sector.